SAN JOSE, Calif., Aug. 14 VNUS(R) MedicalTechnologies, Inc. (Nasdaq: VNUS), a worldwide leader in medical devices forthe minimally invasive treatment of venous reflux disease, is enjoying ...

MINNEAPOLIS, Minnesota – Vascular Solutions, Inc. today announced that it is marketing a reprocessing service for the ClosureFAST radiofrequency ablation catheter in the United States. The ClosureFAST ...

Study Demonstrates Long-Term Durability of the ClosureFast™ Radiofrequency Ablation System for Treatment of Chronic Venous Insufficiency MANSFIELD, Mass.-- Covidien, a leading global provider of ...

May 19, 2010 — Radiofrequency ablation (RFA) using ClosureFAST (VNUS) is similarly effective to laser for varicose veins but causes less postprocedural pain, according to the results of a randomized ...

September 26, 2006 -- The US Food and Drug Administration (FDA) has granted a clinical laboratory improvement amendment waiver for a portable lead test, thereby improving its availability and access, ...

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, today announced that more than 200,000 ClosureFast ® ...

Covidien reports its ClosureFast device has proven itself in a 5-year study--courtesy of Covidien Covidien ($COV) has wrapped up a 5-year study of its ClosureFast ...

DUBLIN - Feb. 10, 2015 - The ClosureFast(TM) endovenous radiofrequency ablation catheter from Medtronic plc (MDT) is safe and effective for the treatment of chronic venous insufficiency (CVI) over ...

Covidien (Mansfield, Massachusetts) reported the five-year results of its ClosureFast long-term European multi-center study in patients with chronic venous insufficiency (CVI). This study evaluates ...

DUBLIN, Ireland--(BUSINESS WIRE)--Covidien plc (NYSE:COV) today announced the six-month results of the VeClose pivotal study, which demonstrated the safety and effectiveness of the VenaSeal™ closure ...